Company news

PYC Therapeutics Limited news in 2018

PYC Therapeutics Limited's news releases, calls and decks from 2018, newest first.

View company

In Vivo Success - peptide vaccine (Amended Graphics)

December 6, 2018

In vivo success - peptide vaccine in Herpes Simplex Virus

December 6, 2018

Successful Delivery of CRIPR/Cas9 into Cells ex vivo

December 3, 2018

FNA Presentation

November 22, 2018

AGM Company Presentation

November 16, 2018

Sept 2018 Quarterly Operations Update and App4C

October 31, 2018

Fourfold Delivery Improvement in a New Lead Candidate

October 29, 2018

R&D Tax Incentive Refund

October 8, 2018

Reinstatement to Official Quotation

September 11, 2018

Phylogica Recapitalisation

September 11, 2018

Suspension from Official Quotation

September 10, 2018

Update on Capital Raising

September 10, 2018

June 2018 Quarterly Operational Update and App4C

July 31, 2018

Achievement of Major Milestone - In vivo Cre Delivery

July 30, 2018

Successful In-vivo Results Peptide Vaccine T-Cell Expansion

July 26, 2018

CEO Update

July 8, 2018

March 2018 Operational Update and Cashflow

April 30, 2018

Changes to Board and Management

April 11, 2018

Cre Enzyme Delivery Provides Validation & Strategic Value

March 1, 2018

Dec 2017 Half-year financial statements & Appendix 4D

February 28, 2018

Dec Quarterly Update and Appendix 4C

January 31, 2018

Federal R&D Tax Credit Received

January 11, 2018

FPP Results Effective in Delivering Peptide Cancer Vaccine

January 8, 2018

Decks in 2018